CN105477375A - 一种治疗胃炎的中药组合物 - Google Patents
一种治疗胃炎的中药组合物 Download PDFInfo
- Publication number
- CN105477375A CN105477375A CN201511023069.7A CN201511023069A CN105477375A CN 105477375 A CN105477375 A CN 105477375A CN 201511023069 A CN201511023069 A CN 201511023069A CN 105477375 A CN105477375 A CN 105477375A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- parts
- chinese medicine
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 7
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 78
- 238000002360 preparation method Methods 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000013543 active substance Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 238000009472 formulation Methods 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 13
- 210000002784 stomach Anatomy 0.000 claims description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 10
- 241000242759 Actiniaria Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000012567 medical material Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- 201000006549 dyspepsia Diseases 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 210000000952 spleen Anatomy 0.000 claims description 4
- 206010000077 Abdominal mass Diseases 0.000 claims description 3
- 206010000087 Abdominal pain upper Diseases 0.000 claims description 3
- 208000002193 Pain Diseases 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 230000004596 appetite loss Effects 0.000 claims description 3
- 230000001174 ascending effect Effects 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 208000024798 heartburn Diseases 0.000 claims description 3
- 208000019017 loss of appetite Diseases 0.000 claims description 3
- 235000021266 loss of appetite Nutrition 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241001083548 Anemone Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241001076416 Dendrobium tosaense Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000146029 Lindera aggregata Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 239000009232 moluodan Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 210000001187 pylorus Anatomy 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- -1 sublimed preparation Substances 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000009854 mucosal lesion Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000590988 Danainae Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本方涉及一种治疗胃炎的中药组合物,所述中药组合物由以下重量配比的中药原料药制备而成,百合30-80重量份、茯苓30-80重量份、生地黄40-90重量份、川芎30-80重量份、鸡内金5-30重量份、乌药30-70重量份、泽泻20-60重量份、天冬50-90重量份、三七5-30重量份、白术10-50重量份、当归20-60重量份、茵陈30-80重量份、地榆50-90重量份、蒲黄20-60重量份、延胡索30-80重量份、白芍120-180重量份、铁皮石斛40-90重量份、九节菖蒲20-60重量份。
Description
发明领域
本发明涉及一种中药组合物的制备方法,特别涉及用于治疗胃炎的中药组合物的制备方法以及用该方法制备的药物制剂。
背景技术
摩罗丹是一种和胃降逆,健脾消胀,通络定痛的药物。用于慢性萎缩性胃炎及胃疼,胀满,痞闷,纳呆,嗳气,烧心等症。用法用量,口服,蜜丸一次9~18g份,一日3次,饭前用米汤或温开水送下,或遵医嘱。其由百合、麦冬、石斛、茯苓、白术(麸炒)、乌药、白芍、三七、延胡索(醋炙)、鸡内金(炒香)、玄参、当归等18味中药制备而成,药理作用如下
1作用:当归对痢疾杆菌、霍乱弧菌、变形杆菌、大肠杆菌均有抑制作用,三七总皂甙对某些真菌有较强抑制作用。
2胃粘膜:本方对胃粘膜损伤有修复作用。
3理研究乌药对胃肠道平滑肌有兴奋和抑制的双向调节作用,促进消化液分泌;鸡内金提高胃液分泌量,酸度和消化能力。
4免疫功能:据药理性实验茯苓、白术除健脾外,有效提高体液免疫功能。
5药理发现本方中三七、当归、茯苓等皆有护肝、解除酒精肝中毒,促进肝中血清转化的功能。
中国专利公开了摩罗丹制剂的以下配方
所述白术用麸炒,延胡索用醋炙,鸡内金选用炒鸡内金。
以及制备方法:
以上十八味,加水煎煮1-3次,每次1.5-3小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达60-80%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,最后经过常规工序直接或加入药学上可接受的赋型剂制成临床可接受的剂型。
中国专利200710120838.4公开了摩罗丹以下含量测定方法,
含量测定如下:
照高效液相色谱法测定;
色谱条件与系统适应性试验:用十八烷基硅烷键合硅胶为填充剂;以15-60:40-85的乙腈-水为流动相;检测波长为230nm,理论板数按芍药苷峰计算应不低于1000~5000;
对照品溶液的制备:精密称取芍药苷对照品适量,加溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯制成每1ml含30-50μg份的溶液,即得;
供试品溶液的制备:取摩罗丹小蜜丸或重量差异项下的大蜜丸,剪碎,精密称取1~10g份,加入硅藻土1~10g份,研匀,置具塞锥形瓶中,精密加入溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯15-25ml,密塞,称重,超声处理或热回流或冷浸提取30分钟,取出放至室温后称重,用溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯补足至15-25ml摇匀,滤过,精密吸取续滤液4-6ml,置10ml量瓶中,加溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯稀释至刻度,摇匀,即得;
测定法:分别精密吸取对照品溶液与供试品溶液各20μl,注入液相色谱仪,测定,即得;摩罗丹每1g份含白芍以芍药苷C23H28O11计,不得少于0.8mg份。
本发明人在临床和生产实践中发现,现有技术在疗效,稳定性,有效成分含量,药物的使用量等方面需要改进,为此本发明人对现有技术进行了改进,从而完成了本发明。
发明内容:
为改进现有技术的缺陷,本发明提供一种摩罗丹的新的中药组合物,所述中药组合物由以下重量配比的中药原料药制备而成,
百合30-80重量份、茯苓30-80重量份、生地黄40-90重量份、川芎30-80重量份、鸡内金5-30重量份、乌药30-70重量份、泽泻20-60重量份、天冬50-90重量份、三七5-30重量份、白术10-50重量份、当归20-60重量份、茵陈30-80重量份、地榆50-90重量份、蒲黄20-60重量份、延胡索30-80重量份、白芍120-180重量份、铁皮石斛40-90重量份、九节菖蒲20-60重量份优选的,本发明所述的中药组合物,由以下重量配比的中药原料药制备而成,
百合60重量份、茯苓60重量份、生地黄65重量份、川芎55重量份、鸡内金15重量份、乌药45重量份、泽泻45重量份、天冬75重量份、三七15重量份、白术30重量份、当归45重量份、茵陈60重量份、地榆75重量份、蒲黄45重量份、延胡索60重量份、白芍150重量份、铁皮石斛75重量份、九节菖蒲45重量份
以上组成中,重量是以生药计算的,以上组成是按重量作为配比的,在生产时可按照相应比例增大或减少,如大规模生产可以以公斤为单位,或以吨为单位,小规模生产也可以以克或毫克为单位,重量可以增大或者减小,但各组成之间的生药材重量配比的比例不变。
以上重量配比的比例是经过科学筛选得到的,对于特殊情况,如重症或轻症,肥胖或瘦小的,可以相应调整组成的量的配比,增加或减少不超过100%,药效不变。
以上组成中的单味中药,尤其是臣药和佐药,也可以被适当的具有相同药性的中药替换,替换后的中药制剂其药物作用不变。
本发明的中药组合物,最佳是药物制剂的形式,是通过将上述配方组成的中药原料经过提取或其他方式加工,制成药物活性物质,随后,以该物质为原料,需要时加入药物可接受的载体,按照制剂学的常规技术制成的。所述活性物质可以通过分别提取中药原料得到,也可以通过共同提取中药原料得到,也可以通过其他方式得到,如:通过粉碎、压榨、煅烧、研磨、过筛、渗漉、萃取、水提、醇提、酯提、酮提、层析等方法得到、这些活性物质可以是浸膏形式的物质,可以是干浸膏也可以是流浸膏,根据制剂的不同需要决定制成不同的浓度。
本发明的中药组合物中的药物活性物质,其在制剂中所占重量百分比可以是0.1-99.9%,其余为药物可接受的载体。作为药物制剂,可以以单位剂量形式存在,所述单位剂量形式是指制剂的单位,如片剂的每片,胶囊的每粒胶囊,口服液的每瓶,颗粒剂每袋等。
本发明的中药制剂可以是任何可药用的剂型,这些剂型包括:片剂、胶囊剂、颗粒剂、丸剂、散剂、膏剂、丹剂、粉剂、溶液剂、注射剂、栓剂、喷雾剂、滴剂、贴剂。本发明的制剂,优选的是口服剂型,如:胶囊剂、片剂、口服液、颗粒剂、丸剂、散剂、丹剂、膏剂等。
本发明的中药制剂,其口服给药的制剂可含有常用的赋形剂,诸如粘合剂、填充剂、稀释剂、压片剂、润滑剂、崩解剂、着色剂、调味剂和湿润剂。
适用的填充剂包括纤维素、甘露糖醇、乳糖和其它类似的填充剂。适宜的崩解剂包括淀粉、聚乙烯吡咯烷酮和淀粉衍生物,例如羟基乙酸淀粉钠。适宜的润滑剂包括,例如硬脂酸镁。适宜的药物可接受的湿润剂包括十二烷基硫酸钠。
可通过混合,填充,压片等常用的方法制备固体口服组合物。进行反复混合可使活性物质分布在整个使用大量填充剂的那些组合物中。
口服液体制剂的形式例如可以是水性或油性悬浮液、溶液、乳剂、糖浆剂或酏剂,或者可以是一种在使用前可用水或其它适宜的载体复配的干燥产品。这种液体制剂可含有常规的添加剂,诸如悬浮剂,例如山梨醇、糖浆、甲基纤维素、明胶、羟乙基纤维素、羧甲基纤维素、硬脂酸铝凝胶或氢化食用脂肪,乳化剂,例如卵磷脂、脱水山梨醇一油酸酯或阿拉伯胶;非水性载体(它们可以包括食用油),例如杏仁油、分馏椰子油、诸如甘油的酯的油性酯、丙二醇或乙醇;防腐剂,例如对羟基苯甲酯或对羟基苯甲酸丙酯或山梨酸,并且如果需要,可含有常规的香味剂或着色剂。
本发明的中药制剂,在制备成药剂时可选择性的加入适合的药物可接受的载体,如常用的辅料成分:甘露醇、山梨醇、焦亚硫酸钠、亚硫酸氢钠、硫代硫酸钠、盐酸半胱氨酸、巯基乙酸、蛋氨酸、维生素C、EDTA二钠、EDTA钙钠,一价碱金属的碳酸盐、醋酸盐、磷酸盐或其水溶液、盐酸、醋酸、硫酸、磷酸、氨基酸、氯化钠、氯化钾、乳酸钠、木糖醇、麦芽糖、葡萄糖、果糖、右旋糖苷、甘氨酸、淀粉、蔗糖、乳糖、甘露糖醇、硅衍生物、纤维素及其衍生物、藻酸盐、明胶、聚乙烯吡咯烷酮、甘油、土温80、琼脂、碳酸钙、碳酸氢钙、表面活性剂、聚乙二醇、环糊精、β-环糊精、磷脂类材料、高岭土、滑石粉、硬脂酸钙、硬脂酸镁等。
本发明的制剂在使用时根据况确定用法用量,可每日服三次,每次1-20剂,如:1-20袋或粒或片。
本发明所述的中药组合物,优选的制备方法,步骤如下:
药材加水煎煮1-3次,每次1.5-3小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达60-80%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
最优选的,本发明所述的制备方法,步骤如下:
药材加水煎煮2次,每次2小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达70%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
本发明所述的中药组合物在制备具有和胃降逆,健脾消胀,通络定痛之功效,治疗胃炎及胃疼,胀满,痞闷,纳呆,嗳气,烧心等症的药物中的应用。
本发明优选的制剂为浓缩丸,其制备方法如下,取药物活性成分、粉碎后药粉每1重量份加0.6-1.5重量份炼蜜制成浓缩蜜丸。
本发明在现有技术的基础上,对配方进行了改进,去掉佐药地榆、使药九节菖蒲2味药,地榆:凉血止血,解毒敛疮;九节菖蒲:开窍化痰,醒脾安神。
本发明中,用生地黄、天冬、铁皮石斛替换现有技术中的三味君药。麦冬与天冬具有润肺养阴;石斛与铁皮石斛具有益胃生津,滋阴清热;玄参与地黄:清热凉血。
本发明的方法和现有技术相比,主要活性成分明显增加,药效明显提高,制剂稳定性明显提高,
以下通过实验数据说明本发明的有益效果:
实验内容:
本发明和现有技术进行对比实验
实验1、对酸性乙醇致大鼠急性胃黏膜损伤的影响
动物分组给药,于给药第7天各组动物分别禁食不禁水48h,试验前各组动物再灌胃给药(水)1次,2h后每只大鼠灌胃酸性乙醇2ml(150mmol/L盐酸与60%乙醇按1∶1比例混合),1h后分别用过量乙醚麻醉大鼠致死,开腹取胃,用夹子夹紧贲门,由幽门注入1%甲醛溶液5ml,夹紧幽门,将全胃置于1%甲醛溶液中固定10min,沿胃大弯剪开,将胃外翻,用清水轻轻洗去内容物,将胃平铺于玻璃板上,用精密卡尺测量胃黏膜损伤长度,以损伤长度(损伤宽度大于1mm者加倍计算)总和作为胃黏膜损伤指数,并计算抑制率。
实验结果如下:
从结果可见,各组大鼠胃黏膜均有不同程度损伤,本发明组和现有技术组均较模型对照组轻,损伤指数明显降低(P<0.05)。
大鼠再生粘膜厚度的比较
组别 | 动物数(只) | 再生粘膜厚度(μm) |
对照组 | 10 | 419 |
模型组 | 10 | 99 |
本发明组 | 10 | 344 |
现有技术组 | 10 | 299 |
溃疡灶肉芽瘢痕层厚度的比较
组别 | 动物数(只) | 肉芽瘢痕层厚度(μm) |
对照组 | 10 | 0 |
模型组 | 10 | 0.59 |
本发明组 | 10 | 0.15 |
现有技术组 | 10 | 0.23 |
实验2、对大鼠胃液分泌的影响
动物分组给药,每组10只大鼠,末次给药后各组动物分别禁食禁水24h,用乙醚麻醉,沿腹中线剪开小口,轻轻拉出胃,结扎幽门,再由十二指肠给药1次,缝合腹壁切口,6h后拆线开腹结扎贲门,摘除全胃,用滤纸擦净血迹,沿胃大弯剪开胃壁,倾出胃内容物,收集于刻度离心管中,以1500r/min速度离心10min,精确记录胃液量,以酚红为指示剂测定胃液总酸度,采用麦特毛细管法测定胃蛋白酶活性。
实验结果如下:
从结果可见,本发明组和现有技术组均可降低胃液总酸度及胃蛋白酶活性(P>0.05)。
实验3、体内抗菌试验:
本发明组和现有技术组均可以减少金黄色葡萄球菌感染小鼠死亡数,延长感染小鼠的存活天数;
实验结果如下:
组别 | 动物数(只) | 死亡数(只) | 存活率% |
正常对照组 | 20 | 0 | 100 |
模型组 | 20 | 12 | 40 |
本发明组 | 20 | 6 | 70 |
现有技术组 | 20 | 9 | 55 |
实验4.抗炎试验结果:
本发明组和现有技术组均可降低二甲苯所致小鼠耳廓肿胀度。
对小鼠迟发型变态反应(足跖增厚法)影响(足跖厚度差值mm)
剂量组 | 动物数(只) | 注射后24h足跖肿胀度(mm) |
阴性对照组 | 10 | 0.214 |
本发明组 | 10 | 0.464 |
现有技术组 | 10 | 0.345 |
实验5、加速稳定性实验
将样品放置在40℃±2℃、相对湿度75%±5%的条件下放置于恒温恒湿箱中,以设定时间取样,对有关成分进行含量测定,试验后的初步稳定性试验结果如下
本发明样品试验后的初步稳定性试验结果
现有技术样品试验后的初步稳定性试验结果
本发明的优点主要表现在:
通过改进配方,取得了以下技术效果:降低了药物的服用量,活性成分的含量有所提高,制剂稳定性有所提高,药物的疗效有所提高。
具体实施方式:
以下通过实施例进一步说明本发明,但不作为对本发明的限制。
实施例1
配方:
百合60重量份、茯苓60重量份、生地黄65重量份、川芎55重量份、鸡内金15重量份、乌药45重量份、泽泻45重量份、天冬75重量份、三七15重量份、白术30重量份、当归45重量份、茵陈60重量份、地榆75重量份、蒲黄45重量份、延胡索60重量份、白芍150重量份、铁皮石斛75重量份、九节菖蒲45重量份
制备方法:
药材加水煎煮2次,每次2小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达70%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
实施例2
配方
百合30重量份、茯苓30重量份、生地黄40重量份、川芎30重量份、鸡内金5重量份、乌药30重量份、泽泻20重量份、天冬50重量份、三七5重量份、白术10重量份、当归20重量份、茵陈30重量份、地榆50重量份、蒲黄20重量份、延胡索30重量份、白芍120重量份、铁皮石斛40重量份、九节菖蒲20重量份
制备方法
药材加水煎煮1次,每次1.5小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达60%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
实施例3
配方
百合80重量份、茯苓80重量份、生地黄90重量份、川芎80重量份、鸡内金30重量份、乌药70重量份、泽泻60重量份、天冬90重量份、三七30重量份、白术50重量份、当归60重量份、茵陈80重量份、地榆90重量份、蒲黄60重量份、延胡索80重量份、白芍180重量份、铁皮石斛90重量份、九节菖蒲60重量份
制备方法
药材加水煎煮3次,每次3小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达80%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
实施例4
胶囊剂的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成胶囊剂
实施例5
片剂的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成片剂
实施例6
丸剂的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成丸剂
实施例7
颗粒剂的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成颗粒剂
实施例8
口服液的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成口服液剂
实施例9
滴丸剂的制备
取实施例1得到的药物活性物质,经过常规的制剂制备方法,制备成滴丸剂。
Claims (7)
1.一种治疗胃炎的中药组合物,所述中药组合物由以下重量配比的中药原料药制备而成,
百合30-80重量份、茯苓30-80重量份、生地黄40-90重量份、川芎30-80重量份、鸡内金5-30重量份、乌药30-70重量份、泽泻20-60重量份、天冬50-90重量份、三七5-30重量份、白术10-50重量份、当归20-60重量份、茵陈30-80重量份、地榆50-90重量份、蒲黄20-60重量份、延胡索30-80重量份、白芍120-180重量份、铁皮石斛40-90重量份、九节菖蒲20-60重量份。
2.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物由以下重量配比的中药原料药制备而成,
百合60重量份、茯苓60重量份、生地黄65重量份、川芎55重量份、鸡内金15重量份、乌药45重量份、泽泻45重量份、天冬75重量份、三七15重量份、白术30重量份、当归45重量份、茵陈60重量份、地榆75重量份、蒲黄45重量份、延胡索60重量份、白芍150重量份、铁皮石斛75重量份、九节菖蒲45重量份。
3.权利要求1所述的中药组合物的制备方法,其特征在于,所述制备方法步骤如下:
药材加水煎煮1-3次,每次1.5-3小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达60-80%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
4.根据权利要求3所述的制备方法,其特征在于,步骤如下:
药材加水煎煮2次,每次2小时,合并煎液,滤过,滤液浓缩至适量,加入乙醇,使含醇量达70%,静置,滤过,回收乙醇,滤液浓缩,加水冷藏,滤过,得到药物活性物质,经过制剂方法,制备成药物制剂组合物。
5.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物为任何一种可服用的药物剂型。
6.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物为胶囊剂,片剂,丸剂,颗粒剂,口服液,滴丸剂,膏剂。
7.权利要求1所述的中药组合物在制备具有和胃降逆,健脾消胀,通络定痛之功效,治疗胃炎及胃疼,胀满,痞闷,纳呆,嗳气,烧心等症的药物中的应用。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511023069.7A CN105477375A (zh) | 2015-12-30 | 2015-12-30 | 一种治疗胃炎的中药组合物 |
PCT/CN2016/073421 WO2017113475A1 (zh) | 2015-12-30 | 2016-02-04 | 一种治疗胃炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511023069.7A CN105477375A (zh) | 2015-12-30 | 2015-12-30 | 一种治疗胃炎的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105477375A true CN105477375A (zh) | 2016-04-13 |
Family
ID=55664885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511023069.7A Pending CN105477375A (zh) | 2015-12-30 | 2015-12-30 | 一种治疗胃炎的中药组合物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105477375A (zh) |
WO (1) | WO2017113475A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115944699B (zh) * | 2022-12-14 | 2024-03-15 | 修正药业集团股份有限公司 | 一种具有运脾益气,消食化滞功效的中药组合物、其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1457829A (zh) * | 2003-04-17 | 2003-11-26 | 邯郸制药有限公司 | 一种治疗慢性萎缩性胃炎的中药组合物及其制备方法和质量控制方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1840092B (zh) * | 2006-01-23 | 2010-05-12 | 北京因科瑞斯生物制品研究所 | 一种摩罗颗粒及其制备方法 |
CN103623343B (zh) * | 2013-11-16 | 2015-10-28 | 王纯治 | 一种治疗嗳气的中药混合物 |
-
2015
- 2015-12-30 CN CN201511023069.7A patent/CN105477375A/zh active Pending
-
2016
- 2016-02-04 WO PCT/CN2016/073421 patent/WO2017113475A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1457829A (zh) * | 2003-04-17 | 2003-11-26 | 邯郸制药有限公司 | 一种治疗慢性萎缩性胃炎的中药组合物及其制备方法和质量控制方法 |
Non-Patent Citations (1)
Title |
---|
张惊湖: "《常用中药功效比较》", 31 March 1999, 第四军医大学出版社 * |
Also Published As
Publication number | Publication date |
---|---|
WO2017113475A1 (zh) | 2017-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014094632A1 (zh) | 一种治疗头痛的药物组合物及其制备方法 | |
CN101569712A (zh) | 一种治疗感冒风寒的中药组合物 | |
CN105535533A (zh) | 一种治疗胃炎的中药组合物 | |
CN106421673A (zh) | 一种治疗hpv病毒感染的中药组合物及其制备方法 | |
CN102614260B (zh) | 一种治疗胃和十二指肠溃疡的药物及其制备方法和用途 | |
CN106620541B (zh) | 一种治疗慢性湿疹的外用中药组合物及其制备方法 | |
CN105477375A (zh) | 一种治疗胃炎的中药组合物 | |
CN105477361B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN101869675B (zh) | 一种治疗暑湿感冒的中药组合物颗粒剂及其制备方法 | |
CN106421572A (zh) | 一种治疗动物泰勒虫病的中药制剂及其制备方法 | |
CN105477360B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN108125237B (zh) | 一种镇咳祛痰抗炎的保健品及其制备工艺 | |
CN105477359B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105535534A (zh) | 一种治疗胃炎的中药组合物 | |
CN105381264A (zh) | 一种治疗胃炎的中药组合物 | |
CN105395895A (zh) | 一种治疗胃炎的中药组合物 | |
CN105535535A (zh) | 一种治疗胃炎的中药组合物 | |
CN105497557A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105456738A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105477362A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN114796432B (zh) | 一种治疗胃炎的中药组合物及其制备方法 | |
CN105477358A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105381259B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105477364B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
CN105395889B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160413 |